Therefore, we obtained a four-m6A-associated gene combination prognostic model for HCC patients (risk score = YTHDF2 × 0.059 + YTHDF1 × 0.027 + METTL3 × 0.066 + KIAA1429 × 0.034, Figure 3(c)). This evidence concerns the gene METTL3 and hepatocellular carcinoma.